Weltpremiere auf der Auto Shanghai 2013, der wichtigsten Automesse in China, feiert das VW CrossBlue Coupé, mit dem die Wolfsburger einen Ausblick in die Zukunft geben. VW-Design-Chef Klaus Bischoff: „Das neue Coupé lebt von einem harmonischen Dreiklang. Es ist robust im Auftritt, sportlich in den Proportionen und von zurückhaltender Eleganz in der Skulptur und den Linien. Diese Studie wird zweifellos Einfluss auf künftige SUV-Modelle haben.
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced that it has acquired Ireland-based QUMAS, a leading global provider of Cloud-based and on-premises enterprise compliance software supporting regulatory and quality operations in life sciences and other highly regulated industries. The QUMAS acquisition further extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions. Proven quality management solutions supported by robust content and business process management capabilities provided by QUMAS advance Accelrys’ ability to help customers better manage the scientific innovation lifecycle by reducing regulatory risks, lowering quality costs, improving compliance effectiveness and increasing operational efficiency in bringing new products to market.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62188-accelrys-acquires-compliance-and-quality-management-leader-qumas
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
Kia Motors America (KMA) today unveiled the all-new 2017 Optima Plug-in Hybrid (PHEV) at the Chicago Auto Show. Kia’s first PHEV joined two other fuel-efficient additions to the brand’s growing line-up of eco-friendly vehicles, including the all-new 2017 Niro Hybrid Utility Vehicle (HUV) and all-new 2017 Optima Hybrid (HEV), all three of which are being introduced under the Kia Motors EcoDynamics environmentally friendly sub-brand. A host of new technologies and features in the Kia Optima PHEV, including a more powerful hybrid engine, a smarter and more robust telematics system, exterior design enhancements, and greater interior refinement, all combine to deliver a superior hybrid drive experience.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7731854-kia-optima-plug-in-hybrid-chicago-auto-show/
